Epilepsy Clinical Trial
Official title:
Studio di Efficacia di Percorsi di Riabilitazione Neuropsicologica Tramite Piattaforma Lumosity: Evidenze Comportamentali e Neurofisiologiche in Pazienti Con Epilessia Non Sintomatica in età Pediatrica
Patients with non-symptomatic epilepsy, even in the presence of a normative cognitive functioning, present different levels of neuropsychological weaknesses, especially in executive functions and social competences. Such difficulties can significantly influence academic achievement and social inclusion. To date, there is limited evidence on small samples that training focusing on executive functions, also through tele-rehabilitation methods, may be effective in limiting these difficulties. Therefore, the purpose of this research project is to evaluate the effectiveness of a training of the executive functions (administered via the Lumosity platform) in patients with non-symptomatic focal and generalized epilepsy. A cognitive and behavioral assessment will be performed before and after the treatment to evaluate its efficacy. Moreover, a predefined neurophysiological marker will be recorded before and after treatment to detect changes in cortical activity which may reflect expected treatment effects.
Status | Not yet recruiting |
Enrollment | 48 |
Est. completion date | February 28, 2022 |
Est. primary completion date | February 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of non-symptomatic epilepsy; - Absence of intellectual disability (total IQ> 70); - Absence of significant visual, auditory or motor impairments that may prevent the use of the computerized training; - Basic ability to use PC. Exclusion Criteria: - Presence of psychiatric comorbidity and / or behavioral disturbances that may hamper the participation to training sessions; - Diagnosis of photosensitive epilepsy. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
IRCCS Eugenio Medea |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NEPSY-II Neuropsychological Battery | Assessment of executive functions, language, memory and visuo-spatial skills Subscales (all subscales range from 1 to 19 scalar scores): Design fluency, raw score 0/70 Auditory attention, 0/30 and Response Set 0/36 Inhibition (denomination 0/80 - 0/360') (inhibition 0/80 - 480') (switching 0/80 - 480') REVERSE (higher raw scores indicate worse perfomance) Animal sorting, 0/12 Word generation, 0/75 Memory for faces, 0/32 Word list interference (repetition 0/20; recall 0/40) Imitating hand position, (0/24) Visuo-motor precision (0/307; 0/360') REVERSE (higher raw scores indicate worse perfomance) Manual motor sequences, 0/60 Affect recognition, 0/35 Design copying (general 0/21; motor 0/42; global 0/42; local 0/36; total specific 0/120) Picture puzzles, 0/20 Geometric puzzles, 0/40 |
baseline | |
Primary | Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV) | Assessment of general intellectual ability. Indexes (higher T scores indicate better perfomance for all indexes) Verbal Comprehension Index (40/160) Fluid Reasoning Index (40/160) Working Memory Index (40/160) Processing Speed Index (40/160) Full Scale IQ (40/160) |
baseline | |
Primary | NEPSY-II Neuropsychological Battery (change) | Assessment of executive functions, language, memory and visuo-spatial skills | within 1 week after intervention | |
Primary | NEPSY-II Neuropsychological Battery (change) | Assessment of executive functions, language, memory and visuo-spatial skills | 3 month after intervention | |
Secondary | Child Behavior Checklist (CBCL) (parent compiled for 6-18 years old participants) | Questionnaire for the assessment of emotional and behavioural problems. The CBCL 6-18 is aimed at assessing psychological adjustment and behavioral functioning of children, as rated by parents. This instrument provides a total score, an internalizing score and an externalizing score, together with 8 syndrome scale scores and 6 DSM-oriented scale scores. It contains 113 items. Raw scores of the Total Problems Scale range from 0 to 226. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
baseline | |
Secondary | Youth Self Report (CBCL self-report version for 11-18 years old participants) | Questionnaire for the assessment of emotional and behavioural problems. YSR 11-18 is direcly compiled by adolescents aged 11-18 years. It provides a total score, an internalizing score and an externalizing score, together with eight empirically based syndromes and DSM-oriented scales. It contains 112 items. Raw scores of the Total Problems Scale range from 0 to 224. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
baseline | |
Secondary | The Children's Quality of Life (TACQOL) | Questionnaire for the assessment of health-related quality of life. Scales (higher raw scores indicate higher quality of life) Body (physical functioning) 0/32 Motor functioning 0/32 Autonomy 0/32 Social functioning 0/32 Cognition 0/32 Emotions (positive) 0/16 Emotions (negative) 0/16 |
baseline | |
Secondary | Behavior Rating Inventory of Executive Function (BRIEF-2) (parent compiled for 5-10 years old participants; self-report version for 11-18 years old participants) | Questionnaire for the assessesment of executive function and self-regulation competence. The BRIEF (parent version) questionnaire is aimed at assessing executive functioning at home and school and contains 63 items. Raw scores of the global scale range from 63 to 189; T scores (M = 50, SD = 10). The self-report version contains 55 items. Raw scores of the global scale range from 55 to 165; T scores (M = 50, SD = 10). Higher scores mean a worse outcome. Subscale and Indexes Inhibit Shift Self-Monitor Emotional Control Initiate Working Memory Plan/Organize Behavioral regulation Index Emotion regulation Index Cognitive regulation Index Global Executive Index |
baseline | |
Secondary | Theta/beta ratio | Low theta/beta ratio is a cortical activity considered an index of poor attentional resources. Its recording will be conducted with a 32-channels EEG system at rest (4 minutes: 2 min eyes open and 2 min eyes closed). | baseline | |
Secondary | Child Behavior Checklist CBCL (change) | Questionnaire for the assessment of emotional and behavioural problems The CBCL 6-18 is aimed at assessing psychological adjustment and behavioral functioning of children, as rated by parents. This instrument provides a total score, an internalizing score and an externalizing score, together with 8 syndrome scale scores and 6 DSM-oriented scale scores. It contains 113 items. Raw scores of the Total Problems Scale range from 0 to 226. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
within 1 week after intervention | |
Secondary | Youth Self Report (CBCL self-report version for 11-18 years old participants) | Questionnaire for the assessment of emotional and behavioural problems. YSR 11-18 is direcly compiled by adolescents aged 11-18 years. It provides a total score, an internalizing score and an externalizing score, together with eight empirically based syndromes and DSM-oriented scales. It contains 112 items. Raw scores of the Total Problems Scale range from 0 to 224. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
within 1 week after intervention | |
Secondary | The Children's Quality of Life TACQOL (change) | Questionnaire for the assessment of health-related quality of life. Scales (higher raw scores indicate higher quality of life) Body (physical functioning) 0/32 Motor functioning 0/32 Autonomy 0/32 Social functioning 0/32 Cognition 0/32 Emotions (positive) 0/16 Emotions (negative) 0/16 |
within 1 week after intervention | |
Secondary | Behavior Rating Inventory of Executive Function (BRIEF-2) (change) | Questionnaire for the assessesment of executive function and self-regulation competence. The BRIEF (parent version) questionnaire is aimed at assessing executive functioning at home and school and contains 63 items. Raw scores of the global scale range from 63 to 189; T scores (M = 50, SD = 10). The self-report version contains 55 items. Raw scores of the global scale range from 55 to 165; T scores (M = 50, SD = 10). Higher scores mean a worse outcome. Subscale and Indexes Inhibit Shift Self-Monitor Emotional Control Initiate Working Memory Plan/Organize Behavioral regulation Index Emotion regulation Index Cognitive regulation Index Global Executive Index |
within 1 week after intervention | |
Secondary | Theta/beta ratio (change) | Low theta/beta ratio is a cortical activity considered an index of poor attentional resources. Its recording will be conducted with a 32-channels EEG system at rest (4 minutes: 2 min eyes open and 2 min eyes closed). | within 1 week after intervention | |
Secondary | Ad-hoc compliance to treatment questionnaire | A 5 items of a 5-point Likert questionnaire created ad-hoc for the assessment of the compliance to the treatment. Higher scores indicare better compliance (except for item 4) |
within 1 week after intervention | |
Secondary | Child Behavior Checklist CBCL (change) | Questionnaire for the assessment of emotional and behavioural problems The CBCL 6-18 is aimed at assessing psychological adjustment and behavioral functioning of children, as rated by parents. This instrument provides a total score, an internalizing score and an externalizing score, together with 8 syndrome scale scores and 6 DSM-oriented scale scores. It contains 113 items. Raw scores of the Total Problems Scale range from 0 to 226. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
3 months after intervention | |
Secondary | Youth Self Report (CBCL self-report version for 11-18 years old participants) | Questionnaire for the assessment of emotional and behavioural problems. YSR 11-18 is direcly compiled by adolescents aged 11-18 years. It provides a total score, an internalizing score and an externalizing score, together with eight empirically based syndromes and DSM-oriented scales. It contains 112 items. Raw scores of the Total Problems Scale range from 0 to 224. T scores (M = 50, SD = 10) are used to interpret the level of behavioral functioning. Higher scores mean a worse outcome. |
3 month after intervention | |
Secondary | The Children's Quality of Life TACQOL (change) | Questionnaire for the assessment of health-related quality of life. Scales (higher raw scores indicate higher quality of life) Body (physical functioning) 0/32 Motor functioning 0/32 Autonomy 0/32 Social functioning 0/32 Cognition 0/32 Emotions (positive) 0/16 Emotions (negative) 0/16 |
3 months after intervention | |
Secondary | Behavior Rating Inventory of Executive Function (BRIEF-2) (change) | Questionnaire for the assessesment of executive function and self-regulation competence. The BRIEF (parent version) questionnaire is aimed at assessing executive functioning at home and school and contains 63 items. Raw scores of the global scale range from 63 to 189; T scores (M = 50, SD = 10). The self-report version contains 55 items. Raw scores of the global scale range from 55 to 165; T scores (M = 50, SD = 10). Higher scores mean a worse outcome. Subscale and Indexes Inhibit Shift Self-Monitor Emotional Control Initiate Working Memory Plan/Organize Behavioral regulation Index Emotion regulation Index Cognitive regulation Index Global Executive Index |
3 month after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A |